人體增強市場－全球產業規模、佔有率、趨勢、機會及預測（依技術、設備、應用、區域及競爭格局分類，2021-2031年）

全球人類增強市場預計將從 2025 年的 180.4 億美元成長到 2031 年的 455.2 億美元，複合年成長率為 16.68%。

該領域涵蓋增強人類認知和身體能力的各種技術，包括神經介面、感覺植入和穿戴式外骨骼。市場加速成長的主要驅動力是重工業對提升工作場所安全性的結構性需求，以及對復健工具的需求，這對全球老化人口至關重要。國際機器人聯合會 (IFR) 發布的 2024 年數據顯示，全球治療和輔助醫療機器人的銷售量將成長 91%，達到約 16,700 台，這印證了上述成長趨勢。這些促進因素表明，技術輔助性能提升正朝著永久性發展，而非曇花一現的消費潮流。

然而，生物識別資料的隱私和所有權問題引發了複雜的監管和倫理挑戰，嚴重阻礙了市場的廣泛擴張。這些設備固有的持續生理監測會帶來法律責任，目前尚缺乏統一的全球管治架構。這種監管的不確定性迫使製造商應對不同的合規標準，不可避免地會延緩產品開發週期，並限制跨境商業活動的即時擴充性。

市場促進因素

義肢和腦機介面（BCI）的技術進步正在從根本上改變整個產業，它們將神經訊號轉化為數位指令，並繞過受損的生物路徑來恢復運動功能。這項創新滿足了龐大人口的迫切需求—根據世界衛生組織（WHO）2024年報告，全球約有13億人患有嚴重殘疾。臨床數據為從研究到商業性化的過程提供了支持。 Synchron公司於2024年9月發布的COMMAND研究結果顯示，所有患者在12個月的追蹤期內均達到了主要安全性終點，且未發生嚴重不利事件。這種可靠性對於建立監管機構的信任至關重要，而這種信任是推動這些介面從小眾臨床試驗走向運動障礙標準治療的關鍵。

同時，人工智慧 (AI) 與穿戴式裝置的快速融合正推動市場成長，使硬體從被動監測工具轉變為主動助理。現代 AI 演算法使設備能夠即時解讀使用者意圖和環境狀況，從而顯著提升聽覺和視覺輔助能力。這項技術革新已迅速轉化為實際的經濟效益。 Meta 公司於 2024 年 10 月發布的 2024 年第三季財報顯示，Reality Labs 的營收年增 29% 至 2.7 億美元，主要得益於 AI 智慧眼鏡的強勁表現。這一趨勢凸顯了車載智慧處理價值創造的關鍵轉折點，顯示人類增強正從醫療應用擴展到更廣泛的消費領域。

市場挑戰

限制全球人類增強市場發展的關鍵障礙之一是圍繞著生物識別資料隱私和所有權的複雜法規環境。隨著製造商開發先進的神經介面和外骨骼，他們面臨全球框架分散、各司法管轄區合規要求差異巨大的局面。缺乏統一的管治企業將大量資金投入在地化和法律實質審查，而非產品創新。因此，這些整合系統的開發週期漫長，直接阻礙了其在國際市場上的快速商業性化擴張。

此外，資料外洩法律責​​任的不確定性也令機構投資人猶豫不決。生理資料的持續監測使得敏感資訊處理的責任歸屬不明，從而構成了一道重要的進入門檻。美國醫學會 (AMA) 2024 年的一項調查也印證了這種擔憂，該調查發現，87% 的醫生認為「強力的資料隱私保障是採用數位醫療和增強智慧工具的先決條件」。主要醫療採用者的這種猶豫不決表明，監管的不確定性正在造成市場規模瓶頸，並阻礙性能增強技術的應用。

市場趨勢

工業外骨骼領域向軟體機器人的轉變，標誌著從笨重僵硬的機械外骨骼向輕便的纖維基主動系統邁出了重要一步。與限制運動範圍的傳統硬殼外骨骼不同，新一代軟體外骨骼採用人工智慧驅動的致動器，提供自適應支撐，旨在減輕物流和製造環境中工人的疲勞。隨著企業在不犧牲靈活性的前提下優先考慮人體工學安全性，這種發展趨勢正在加速其商業應用。例如，德國Bionic公司開發的「Exia」外骨骼（《機器人報告》2025年5月報告），這些智慧系統利用機器學習技術適應使用者動作，並提供高達38公斤的動態舉重輔助，有效減輕高頻作業中的肌肉骨骼壓力。

同時，人工智慧驅動的仿生義肢及其觸覺回饋技術的廣泛應用，正在彌合生物感覺與義肢功能之間的鴻溝，從而徹底改變義肢假體產業。製造商正在開發耐用的多點觸控手，並具備即時觸覺響應功能，與被動式義肢相比，能夠感知壓力和紋理，從而實現更卓越的運動控制和動覺感知。這項技術的成熟正在推動顯著的財務成長；Psyonic公司於2025年4月向美國證券交易委員會（SEC）提交的2024年度報告顯示，由於其觸覺感測「Ability Hand」的商業化部署，公司收入成長了204%。這一快速成長證實了市場對能夠成功將強大的硬體與先進的感測功能相結合的仿生設備的需求日益成長。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球人體增強市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依科技分類​​（穿戴裝置、虛擬實境、擴增實境、外骨骼、智慧虛擬助理）
  • 依裝置類型（穿戴式、非穿戴式）
  • 依應用領域（醫療、航太與國防、體育與公用事業、媒體與娛樂、教育、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美人體增強市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲人體增強市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區人體增強市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東與非洲人體增強市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章 南美洲人體增強市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球人體增強市場：SWOT分析

第14章 波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Ekso Bionics Holdings, Inc.
• B-Temia Inc.
• Medtronic plc
• Cyberdyne Inc.
• ReWalk Robotics Ltd.
• Second Sight Medical Products, Inc.
• BrainGate Company
• Hocoma AG
• Raytheon Company
• Samsung Electronics Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Human Augmentation Market is projected to expand from USD 18.04 Billion in 2025 to USD 45.52 Billion by 2031, registering a CAGR of 16.68%. This sector encompasses technologies intended to boost human cognitive and physical capabilities, including neural interfaces, sensory implants, and wearable exoskeletons. The market's acceleration is primarily fueled by structural needs for enhanced operational safety in heavy industries and essential rehabilitation tools for an aging global population. Evidence of this upward trend is found in 2024 data from the International Federation of Robotics, which reported a 91% increase in global sales of medical robots for therapy and assistance, reaching approximately 16,700 units. These drivers represent a permanent evolution toward technologically assisted performance rather than temporary consumer fads.

However, widespread market expansion is significantly hindered by complex regulatory and ethical hurdles regarding the privacy and ownership of biometric data. The continuous physiological monitoring inherent to these devices introduces legal liabilities that currently lack a unified global governance framework. This regulatory uncertainty compels manufacturers to navigate disjointed compliance standards, which inevitably slows down product development cycles and restricts the immediate scalability of commercial operations across international borders.

Market Driver

Technological advancements in Neuroprosthetics and Brain-Computer Interfaces are fundamentally reshaping the industry by translating neural signals into digital commands, thereby restoring mobility by bypassing damaged biological pathways. This innovation addresses a critical need for a vast demographic, as the World Health Organization reported in 2024 that approximately 1.3 billion people globally suffer from significant disabilities. The progression from research to commercial viability is supported by clinical data; Synchron's September 2024 'COMMAND Study Results' indicated that 100% of patients achieved the primary safety endpoint with no serious adverse events over 12 months. Such reliability is vital for establishing the regulatory confidence necessary to transition these interfaces from niche trials to standard medical treatments for motor impairment.

Simultaneously, the rapid integration of Artificial Intelligence into wearable devices is fueling market growth by evolving hardware from passive monitoring tools into proactive assistants. Modern AI algorithms enable devices to interpret user intent and environmental context in real-time, drastically improving hearing and vision augmentation capabilities. This technological upgrade has generated immediate financial results, as shown in Meta's 'Third Quarter 2024 Results' from October 2024, where Reality Labs revenue grew by 29% year-over-year to $270 million, driven by AI-enabled smart glasses. This trend highlights a decisive shift where value is generated through onboard intelligent processing, extending human augmentation beyond medical use into broad consumer utility.

Market Challenge

The principal obstacle constraining the Global Human Augmentation Market is the intricate regulatory environment concerning biometric data privacy and ownership. As manufacturers engineer advanced neural interfaces and exoskeletons, they face a fragmented global framework where compliance mandates vary drastically across jurisdictions. This absence of unified governance forces companies to redirect significant capital toward localization and legal due diligence rather than product innovation. Consequently, the development timelines for these integrated systems are prolonged, which directly impedes rapid commercial scalability across international markets.

Additionally, the uncertainty surrounding legal liability for data breaches engenders significant hesitation among institutional buyers. The continuous monitoring of physiological data creates undefined accountability regarding the handling of sensitive information, acting as a substantial barrier to entry. This friction is underscored by 2024 findings from the American Medical Association, where 87% of physicians stated that robust data privacy assurances are a prerequisite for adopting digital health and augmented intelligence tools. This reluctance from key medical adopters illustrates how regulatory ambiguity creates a bottleneck in market volume and suppresses the deployment of performance-enhancing technologies.

Market Trends

The shift toward Soft Robotics in industrial exoskeletons represents a major transition from bulky, rigid mechanical suits to lightweight, textile-based active systems. Unlike legacy hard-shell models that limit range of motion, next-generation soft exosuits employ AI-driven actuators to provide adaptive support designed to mitigate worker fatigue in logistics and manufacturing. This evolution is hastening commercial adoption as firms prioritize ergonomic safety without sacrificing agility. As reported by The Robot Report in May 2025 regarding German Bionic's 'Exia' suit, these intelligent systems offer up to 38 kg of dynamic lift assistance while adapting to user movements via machine learning, effectively reducing musculoskeletal strain in high-frequency tasks.

Concurrently, the proliferation of AI-Powered Bionic Limbs with Sensory Feedback is revolutionizing the restorative hardware sector by bridging the gap between biological sensation and prosthetic functionality. Manufacturers are developing durable, multi-touch hands that provide real-time haptic responses, enabling users to perceive pressure and texture for superior motor control and embodiment compared to passive devices. This technological maturity is driving substantial financial growth; Psyonic's April 2025 'Annual Report for Fiscal Year 2024' filed with the SEC noted a 204% increase in revenue attributed to the commercial expansion of its touch-sensing Ability Hand. This surge confirms increasing market demand for bionic devices that successfully combine rugged hardware with advanced sensory capabilities.

Key Market Players

• Ekso Bionics Holdings, Inc.
• B-Temia Inc.
• Medtronic plc
• Cyberdyne Inc.
• ReWalk Robotics Ltd.
• Second Sight Medical Products, Inc.
• BrainGate Company
• Hocoma AG
• Raytheon Company
• Samsung Electronics Co., Ltd.

Report Scope

In this report, the Global Human Augmentation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Human Augmentation Market, By Technology

• Wearable
• Virtual Reality
• Augmented Reality
• Exoskeleton
• Intelligent Virtual Assistant

Human Augmentation Market, By Device

• Body Worn
• Non-Body Worn

Human Augmentation Market, By Application

• Medical
• Aerospace & Defense
• Sports & Utility
• Media & Entertainment
• Education
• Others

Human Augmentation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Human Augmentation Market.

Available Customizations:

Global Human Augmentation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Human Augmentation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Wearable, Virtual Reality, Augmented Reality, Exoskeleton, Intelligent Virtual Assistant)
  • 5.2.2. By Device (Body Worn, Non-Body Worn)
  • 5.2.3. By Application (Medical, Aerospace & Defense, Sports & Utility, Media & Entertainment, Education, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Human Augmentation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Device
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Human Augmentation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Device
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Human Augmentation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Device
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Human Augmentation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Device
      • 6.3.3.2.3. By Application

7. Europe Human Augmentation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Device
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Human Augmentation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Device
      • 7.3.1.2.3. By Application
  • 7.3.2. France Human Augmentation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Device
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Human Augmentation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Device
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Human Augmentation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Device
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Human Augmentation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Device
      • 7.3.5.2.3. By Application

8. Asia Pacific Human Augmentation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Device
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Human Augmentation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Device
      • 8.3.1.2.3. By Application
  • 8.3.2. India Human Augmentation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Device
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Human Augmentation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Device
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Human Augmentation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Device
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Human Augmentation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Device
      • 8.3.5.2.3. By Application

9. Middle East & Africa Human Augmentation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Device
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Human Augmentation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Device
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Human Augmentation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Device
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Human Augmentation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Device
      • 9.3.3.2.3. By Application

10. South America Human Augmentation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Device
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Human Augmentation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Device
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Human Augmentation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Device
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Human Augmentation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Device
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Human Augmentation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Ekso Bionics Holdings, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. B-Temia Inc.
• 15.3. Medtronic plc
• 15.4. Cyberdyne Inc.
• 15.5. ReWalk Robotics Ltd.
• 15.6. Second Sight Medical Products, Inc.
• 15.7. BrainGate Company
• 15.8. Hocoma AG
• 15.9. Raytheon Company
• 15.10. Samsung Electronics Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer